Prof Jennifer Keiser heads the Helminth Drug Development Unit at Swiss TPH, which maintains a large and unique set of helminth-rodent models. She is also a Professor of Neglected Tropical Diseases in the Faculty of Science at the University of Basel. Her team’s research objectives include in vitro and in vivo evaluations of the biological activities of chemical compounds, assay development, preclinical studies such as pharmacokinetics and metabolism and clinical trials in helminthiasis-endemic countries, particularly in Côte d’Ivoire, the Lao People’s Democratic Republic, Russia and Tanzania. Prof Keiser holds a five-year ERC Advanced Grant and is leading a five-year multi-partner EU grant to develop new drugs against neglected helminth infections.